Graduated Recovery Intervention for Early Schizophrenia
早期精神分裂症的分级康复干预
基本信息
- 批准号:6923389
- 负责人:
- 金额:$ 17.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:behavioral /social science research tagclinical researchclinical trialscounselingdisease /disorder onseteducational resource design /developmentfunctional abilityhandbookhealth behaviorhealth care personnel educationhospital utilizationhuman subjecthuman therapy evaluationmedical rehabilitation related tagpatient oriented researchpsychosocial rehabilitationrelapse /recurrenceschizophreniasign /symptomsocial behaviorsubstance abuse related disordertherapy compliancetherapy design /development
项目摘要
DESCRIPTION (provided by applicant): The proposed research has the following goals: 1) Develop and standardize a manual-based individual therapy for first-episode (FE) schizophrenia that is sensitive to the early stages of recovery from initial psychosis (i.e., the "Graduated Recovery Intervention Program;" GRIP); 2) Pilot test GRIP in a small-scale randomized controlled trial (RCT) to obtain specific intervention parameters, including effect sizes and attrition rates, as well as preliminary efficacy data; and 3) Collect preliminary data on intervention moderators and mediators. To achieve these goals, we will conduct the proposed research in three stages. During the first stage, we will refine and standardize the GRIP manual. In the second stage, we will conduct an open, uncontrolled pilot test of the intervention on 6 patients. Following the open trial, we will develop a final version of the GRIP manual. In the third phase of the research, we will conduct a small pilot randomized controlled trial of GRIP (n=25) versus supportive counseling (SC; n=25) for individuals with FE schizophrenia spectrum disorders (i.e., schizophrenia; schizoaffective disorder; schizophreniform disorder). Participants will be assessed at baseline, mid-treatment, post-treatment, and three-month follow-up on a variety of outcome measures, including social functioning, substance use, medication attitudes and adherence, rehospitalization, and symptoms.
描述(由申请人提供):拟议的研究有以下目标:1)开发和标准化对首发精神分裂症的早期康复敏感的手动个体化治疗(即“渐进式康复干预计划;”GRIP);2)在一项小规模随机对照试验(RCT)中进行试点测试GRIP,以获得具体的干预参数,包括效果大小、流失率和初步疗效数据;以及3)收集关于干预主持人和调解人的初步数据。为了达到这些目标,我们将分三个阶段进行拟议的研究。在第一阶段,我们将细化和规范握法手册。在第二阶段,我们将对6名患者进行开放、非对照的干预先导试验。在公开试用之后,我们将开发GRIP手册的最终版本。在研究的第三阶段,我们将对患有精神分裂症谱系障碍(即精神分裂症;分裂情感障碍;分裂样障碍)的个体进行一项小型试点随机对照试验,即GRIP(n=25)和支持性咨询(SC;n=25)。参与者将在基线、治疗中期、治疗后和三个月的随访中接受各种结果测量的评估,包括社会功能、物质使用、用药态度和依从性、再次住院和症状。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Lewis PENN其他文献
DAVID Lewis PENN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Lewis PENN', 18)}}的其他基金
Social Cognition and Interaction Training for Schizophrenia
精神分裂症的社会认知和互动训练
- 批准号:
7241834 - 财政年份:2007
- 资助金额:
$ 17.17万 - 项目类别:
Social Cognition and Interaction Training for Schizophrenia
精神分裂症的社会认知和互动训练
- 批准号:
7425957 - 财政年份:2007
- 资助金额:
$ 17.17万 - 项目类别:
Social Cognition and Interaction Training for Schizophrenia
精神分裂症的社会认知和互动训练
- 批准号:
7625952 - 财政年份:2007
- 资助金额:
$ 17.17万 - 项目类别:
Graduated Recovery Intervention for Early Schizophrenia
早期精神分裂症的分级康复干预
- 批准号:
7059851 - 财政年份:2005
- 资助金额:
$ 17.17万 - 项目类别:
Graduated Recovery Intervention for Early Schizophrenia
早期精神分裂症的分级康复干预
- 批准号:
7215212 - 财政年份:2005
- 资助金额:
$ 17.17万 - 项目类别:
相似海外基金
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 17.17万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 17.17万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10617997 - 财政年份:2022
- 资助金额:
$ 17.17万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10538151 - 财政年份:2021
- 资助金额:
$ 17.17万 - 项目类别:
Admin. Supp. for NCI P30 Cancer Center Grants to Facilitate the Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites
行政。
- 批准号:
10442122 - 财政年份:2021
- 资助金额:
$ 17.17万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10624966 - 财政年份:2021
- 资助金额:
$ 17.17万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10515803 - 财政年份:2021
- 资助金额:
$ 17.17万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10258627 - 财政年份:2021
- 资助金额:
$ 17.17万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10581505 - 财政年份:2019
- 资助金额:
$ 17.17万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10379715 - 财政年份:2019
- 资助金额:
$ 17.17万 - 项目类别:














{{item.name}}会员




